Decreased linear ubiquitination of NEMO and FADD on apoptosis with caspase-mediated cleavage of HOIP

Biochemical and Biophysical Research Communications

Volumn 485, Issue 1, 2017, Pages 152-159

  Goto, Eiji ^a   Tokunaga, Fuminori ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Caspase; Deubiquitinase; NF B; Ubiquitin

Indexed keywords

CASPASE; CASPASE 3; FAS ASSOCIATED DEATH DOMAIN PROTEIN; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; PROTEIN HOIP; UNCLASSIFIED DRUG; FADD PROTEIN, HUMAN; I KAPPA B KINASE; IKBKG PROTEIN, HUMAN; RNF31 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR; UBIQUITIN PROTEIN LIGASE;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DEGRADATION; DISEASES; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; UBIQUITINATION; GENE INACTIVATION; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; JURKAT CELL LINE; METABOLISM;

APOPTOSIS; CASPASES; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENE KNOCKOUT TECHNIQUES; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; JURKAT CELLS; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 85012878394     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.02.040     Document Type: Article

References (24)

1. [1] Zhang, Q., Lenardo, M.J., Baltimore, D., 30 Years of NF-κB: a blossoming of relevance to human pathobiology. Cell 168 (2017), 37–57.
2. [2] Kirisako, T., Kamei, K., Murata, S., Kato, M., Fukumoto, H., Kanie, M., Sano, S., Tokunaga, F., Tanaka, K., Iwai, K., A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25 (2006), 4877–4887.
3. [3] Tokunaga, F., Sakata, S., Saeki, Y., Satomi, Y., Kirisako, T., Kamei, K., Nakagawa, T., Kato, M., Murata, S., Yamaoka, S., Yamamoto, M., Akira, S., Takao, T., Tanaka, K., Iwai, K., Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat. Cell. Biol. 11 (2009), 123–132.
4. [4] Gerlach, B., Cordier, S.M., Schmukle, A.C., Emmerich, C.H., Rieser, E., Haas, T.L., Webb, A.I., Rickard, J.A., Anderton, H., Wong, W.W., Nachbur, U., Gangoda, L., Warnken, U., Purcell, A.W., Silke, J., Walczak, H., Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471 (2011), 591–596.
5. [5] Sasaki, K., Iwai, K., Roles of linear ubiquitinylation, a crucial regulator of NF-κB and cell death, in the immune system. Immunol. Rev. 266 (2015), 175–189.
6. [6] Shimizu, Y., Taraborrelli, L., Walczak, H., Linear ubiquitination in immunity. Immunol. Rev. 266 (2015), 190–207.
7. [7] Sasaki, Y., Sano, S., Nakahara, M., Murata, S., Kometani, K., Aiba, Y., Sakamoto, S., Watanabe, Y., Tanaka, K., Kurosaki, T., Iwai, K., Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells. EMBO J. 32 (2013), 2463–2476.
8. [8] Joo, D., Tang, Y., Blonska, M., Jin, J., Zhao, X., Lin, X., Regulation of linear ubiquitin chain assembly complex by caspase-mediated cleavage of RNF31. Mol. Cell. Biol. 36 (2016), 3010–3018.
9. [9] Peltzer, N., Rieser, E., Taraborrelli, L., Draber, P., Darding, M., Pernaute, B., Shimizu, Y., Sarr, A., Draberova, H., Montinaro, A., Martinez-Barbera, J.P., Silke, J., Rodriguez, T.A., Walczak, H., HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death. Cell. Rep. 9 (2014), 153–165.
10. [10] Hayden, M.S., Ghosh, S., NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes. Dev. 26 (2012), 203–234.
11. [11] Elliott, P.R., Nielsen, S.V., Marco-Casanova, P., Fiil, B.K., Keusekotten, K., Mailand, N., Freund, S.M., Gyrd-Hansen, M., Komander, D., Molecular basis and regulation of OTULIN-LUBAC interaction. Mol. Cell. 54 (2014), 335–348.
12. [12] Schaeffer, V., Akutsu, M., Olma, M.H., Gomes, L.C., Kawasaki, M., Dikic, I., Binding of OTULIN to the PUB domain of HOIP controls NF-κB signaling. Mol. Cell. 54 (2014), 349–361.
13. [13] Elliott, P.R., Leske, D., Hrdinka, M., Bagola, K., Fiil, B.K., McLaughlin, S.H., Wagstaff, J., Volkmar, N., Christianson, J.C., Kessler, B.M., Freund, S.M., Komander, D., Gyrd-Hansen, M., SPATA2 links CYLD to LUBAC, activates CYLD, and controls LUBAC signaling. Mol. Cell. 63 (2016), 990–1005.
14. [14] Kupka, S., De Miguel, D., Draber, P., Martino, L., Surinova, S., Rittinger, K., Walczak, H., SPATA2-mediated binding of CYLD to HOIP enables CYLD recruitment to signaling complexes. Cell. Rep. 16 (2016), 2271–2280.
15. [15] Dondelinger, Y., Darding, M., Bertrand, M.J., Walczak, H., Poly-ubiquitination in TNFR1-mediated necroptosis. Cell. Mol. Life Sci. 73 (2016), 2165–2176.
16. [16] Niu, J., Shi, Y., Iwai, K., Wu, Z.H., LUBAC regulates NF-κB activation upon genotoxic stress by promoting linear ubiquitination of NEMO. EMBO J. 30 (2011), 3741–3753.
17. [17] Mackay, C., Carroll, E., Ibrahim, A.F., Garg, A., Inman, G.J., Hay, R.T., Alpi, A.F., E3 ubiquitin ligase HOIP attenuates apoptotic cell death induced by cisplatin. Cancer Res. 74 (2014), 2246–2257.
18. [18] Vlantis, K., Wullaert, A., Polykratis, A., Kondylis, V., Dannappel, M., Schwarzer, R., Welz, P., Corona, T., Walczak, H., Weih, F., Klein, U., Kelliher, M., Pasparakis, M., NEMO prevents RIP kinase 1-mediated epithelial cell death and chronic intestinal inflammation by NF-κB-dependent and -independent functions. Immunity 44 (2016), 553–567.
19. [19] Welz, P.S., Wullaert, A., Vlantis, K., Kondylis, V., Fernandez-Majada, V., Ermolaeva, M., Kirsch, P., Sterner-Kock, A., van Loo, G., Pasparakis, M., FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477 (2011), 330–334.
20. [20] Keusekotten, K., Elliott, P.R., Glockner, L., Fiil, B.K., Damgaard, R.B., Kulathu, Y., Wauer, T., Hospenthal, M.K., Gyrd-Hansen, M., Krappmann, D., Hofmann, K., Komander, D., OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell 153 (2013), 1312–1326.
21. [21] Damgaard, R.B., Walker, J.A., Marco-Casanova, P., Morgan, N.V., Titheradge, H.L., Elliott, P.R., McHale, D., Maher, E.R., McKenzie, A.N., Komander, D., The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity. Cell 166 (2016), 1215–1230 e1220.
22. [22] Zhou, Q., Yu, X., Demirkaya, E., Deuitch, N., Stone, D., Tsai, W.L., Kuehn, H.S., Wang, H., Yang, D., Park, Y.H., Ombrello, A.K., Blake, M., Romeo, T., Remmers, E.F., Chae, J.J., Mullikin, J.C., Guzel, F., Milner, J.D., Boehm, M., Rosenzweig, S.D., Gadina, M., Welch, S.B., Ozen, S., Topaloglu, R., Abinun, M., Kastner, D.L., Aksentijevich, I., Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc. Natl. Acad. Sci. U S A. 113 (2016), 10127–10132.
23. [23] Sato, Y., Goto, E., Shibata, Y., Kubota, Y., Yamagata, A., Goto-Ito, S., Kubota, K., Inoue, J., Takekawa, M., Tokunaga, F., Fukai, S., Structures of CYLD USP with Met1- or Lys63-linked diubiquitin reveal mechanisms for dual specificity. Nat. Struct. Mol. Biol. 22 (2015), 222–229.
24. [24] Draber, P., Kupka, S., Reichert, M., Draberova, H., Lafont, E., de Miguel, D., Spilgies, L., Surinova, S., Taraborrelli, L., Hartwig, T., Rieser, E., Martino, L., Rittinger, K., Walczak, H., LUBAC-recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes. Cell. Rep. 13 (2015), 2258–2272.